Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target

Molecular and Cellular Proteomics

Volumn 10, Issue 12, 2011, Pages

  Van Houdt, W J ^a,c   Emmink, B L ^a   Pham, T V ^b   Piersma, S R ^b   Verheem, A ^a   Vries, R G ^a   Fratantoni, S A ^b   Pronk, A ^c   Clevers, H ^a   Borel Rinkes, I H M ^a   Jimenez, C R ^b   Kranenburg, O ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b University of Amsterdam   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIRC6 PROTEIN; CISPLATIN; INHIBITOR OF APOPTOSIS PROTEIN; OXALIPLATIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BIRC6 PROTEIN, HUMAN; OXIPLATIN; PLATINUM COMPLEX; PYRIDINE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CELL DEATH; CHEMOSENSITIVITY; COLON CANCER; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROGENY; PROTEOMICS; TANDEM MASS SPECTROMETRY; UPREGULATION; ADENOCARCINOMA; CELL DIFFERENTIATION; COLON TUMOR; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; MOLECULAR GENETICS; MOLECULARLY TARGETED THERAPY; MULTICELLULAR SPHEROID; PATHOLOGY; PROTEIN PROTEIN INTERACTION; TUMOR CELL CULTURE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CISPLATIN; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR TARGETED THERAPY; NEOPLASTIC STEM CELLS; ORGANOPLATINUM COMPOUNDS; PROTEIN INTERACTION MAPS; PROTEOMICS; PYRIDINES; SPHEROIDS, CELLULAR; TANDEM MASS SPECTROMETRY; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 83055168538     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.011353     Document Type: Article

References (37)

1. Chau, I., and Cunningham, D. (2009) Treatment in advanced colorectal cancer: what, when and how? Br. J. Cancer 100, 1704-1719
2. Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., and De Maria, R. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115 (Pubitemid 46067311)
3. O'Brien, C. A., Pollett, A., Gallinger, S., and Dick, J. E. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (Pubitemid 46067310)
4. Todaro, M., Francipane, M. G., Medema, J. P., and Stassi, G. (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138, 2151-2162
5. Vermeulen, L., Todaro, M., de Sousa, M. F., Sprick, M. R., Kemper, K., Perez, A. M., Richel, D. J., Stassi, G., and Medema, J. P. (2008) Singlecell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. U.S.A. 105, 13427-13432
6. Barker, N., Ridgway, R. A., van Es, J. H., van de, W. M., Begthel, H., van den, B. M., Danenberg, E., Clarke, A. R., Sansom, O. J., and Clevers, H. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611
7. Zhu, L., Gibson, P., Currle, D. S., Tong, Y., Richardson, R. J., Bayazitov, I. T., Poppleton, H., Zakharenko, S., Ellison, D. W., and Gilbertson, R. J. (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603-607
8. Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H., Jones, D. L., Visvader, J., Weissman, I. L., and Wahl, G. M. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66, 9339-9344
9. Hamburger, A. W., and Salmon, S. E. (1977) Primary bioassay of human tumor stem cells. Science 197, 461-463
10. Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., and Stassi, G. (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389-402 (Pubitemid 47506537)
11. Dylla, S. J., Beviglia, L., Park, I. K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., Clarke, M. F., Hoey, T., Lewicki, J., and Gurney, A. L. (2008) Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS. ONE. 3, e2428
12. Dean, M., Fojo, T., and Bates, S. (2005) Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275-284 (Pubitemid 40488633)
13. Dean, M. (2009) ABC transporters, drug resistance, and cancer stem cells. J. Mammary. Gland. Biol. Neoplasia. 14, 3-9
14. Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., and Yu, J. S. (2006) Analysis of gene expressio! and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5, 67
15. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., and Heeschen, C. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323 (Pubitemid 47355323)
16. Emmink, B. L., van Houdt, W. J., Vries, R. G., Hoogwater, F. J. H., Nijkamp, M. W., Govaert. K. M., Verheem, A., Steller, E. J. A., Jimenez, C. R., Clevers, H., Borel Rinkes, I. H. M., and Kranenburg, O. (2011) Differentiated colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology 141, 269-278
17. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858
18. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392 (Pubitemid 35215372)
19. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658 (Pubitemid 37082259)
20. Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., and Boman, B. M. (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382-3389
21. Chu, L., Gu, J., Sun, L., Qian, Q., Qian, C., and Liu, X. (2008) Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil. Gene Ther. 15, 484-494 (Pubitemid 351405088)
22. Chen, Z., Naito, M., Hori, S., Mashima, T., Yamori, T., and Tsuruo, T. (1999) A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem. Biophys. Res. Commun. 264, 847-854
23. Lopergolo, A., Pennati, M., Gandellini, P., Orlotti, N. I., Poma, P., Daidone, M. G., Folini, M., and Zaffaroni, N. (2009) Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. Br. J. Cancer 100, 739-746
24. Bianchini, M., Levy, E., Zucchini, C., Pinski, V., Macagno, C., De, S. P., Valvassori, L., Carinci, P., and Mordoh, J. (2006)Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int. J. Oncol. 29, 83-94
25. Salvesen, G. S., and Duckett, C. S. (2002) IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3, 401-410 (Pubitemid 34685698)
26. Deveraux, Q. L., Stennicke, H. R., Salvesen, G. S., and Reed, J. C. (1999) Endogenous inhibitors of caspases. J. Clin. Immunol. 19, 388-398 (Pubitemid 30039106)
27. Eramo, A., Ricci-Vitiani, L., Zeuner, A., Pallini, R., Lotti, F., Sette, G., Pilozzi, E., Larocca, L. M., Peschle, C., and De, M. R. (2006) Chemotherapy resistance of glioblastoma stem cells. Cell Death. Differ. 13, 1238-1241 (Pubitemid 43905604)
28. Signore, M., Ricci-Vitiani, L., and De, M. R. (2011) Targeting apoptosis pathways in cancer stem cells. Cancer Lett
29. Di Stefano, A. B., Iovino, F., Lombardo, Y., Eterno, V., Hoger, T., Dieli, F., Stassi, G., and Todaro, M. (2010) Survivin is regulated by interleukin-4 in colon cancer stem cells. J. Cell. Physiol. 225, 555-561
30. Yang, L., Cao, Z., Yan, H., and Wood, W. C. (2003) Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 63, 6815-6824 (Pubitemid 37322964)
31. Chen, D. J., and Huerta, S. (2009) Smac mimetics as new cancer therapeutics. Anticancer Drugs 20, 646-658
32. Flygare, J. A., and Fairbrother, W. J. (2010) Small-molecule pan-IAP antagonists: a patent review. Expert. Opin. Ther. Pat 20, 251-267
33. Oost, T. K., Sun, C., Armstrong, R. C., Al-Assaad, A. S., Betz, S. F., Deckwerth, T. L., Ding, H., Elmore, S. W., Meadows, R. P., Olejniczak, E. T., Oleksijew, A., Oltersdorf, T., Rosenberg, S. H., Shoemaker, A. R., Tomaselli, K. J., Zou, H., and Fesik, S. W. (2004) Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J. Med. Chem. 47, 4417-4426 (Pubitemid 39096830)
34. Fulda, S., Wick, W., Weller, M., and Debatin, K. M. (2002) Smac agonists sensitize for Apo2L/T. Nat. Med. 8, 808-815
35. Gyrd-Hansen, M., and Meier, P. (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 10, 561-574
36. Fulda, S. (2008) Targeting inhibitor of apoptosis proteins (IAPs) for cancer therapy. Anticancer Agents Med. Chem. 8, 533-539
37. Chen, D. J., and Huerta, S. (2009) Smac mimetics as new cancer therapeutics. Anticancer Drugs 20, 646-658